DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Equine Pharmaceuticals and Supplements Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2023" report to their offering.
The global equine pharmaceuticals and supplements market is projected to grow with a CAGR of 2.0 % to 2.5% from 2017 to 2023.
Governments and various animal health institutions spread awareness about the need for good healthy diets and health supplements for the growth and healthy life of the horses among the horse breeders and trainers in various equine industries. Moreover, they provide information and awareness about the need for prevention of certain diseases and the remedy for some medical conditions. Increasing awareness about equine pharmaceuticals and supplements products is driving the growth of the global equine pharmaceuticals and supplements market.
Demand for herbal digestive, feed, and energy supplements for horses are increasing due to the preference among horse breeders and trainers for natural products and it is expected to drive the growth of the pharmaceuticals and supplements market. The horseracing and equestrian sectors drive the demand for equine pharmaceutical products, as the health of the horses are very important for sustaining the growth of those sectors. Healthy horses in these sectors provide the impetus for the betting and gambling industries related to horse racing. Therefore, most of the trainers and breeders of horses adopt advanced pharmaceutical products for preventing illnesses and for healing the diseases, so that the horses are in good shape for the races.
Stringent regulations regarding the pharmaceutical products and supplements is a major restraint for the market. Availability of alternative betting and gambling avenues affect the equine related industries in matured economies and it is expected to be a restraint for the growth for global equine pharmaceuticals and supplements market. Expansion of horse racing in certain geographical regions is expected to provide opportunities for major players the global equine pharmaceuticals and supplements market to expand. However, the decrease in breeding of horses has led to a decrease in population of horses and it is expected to remain as a major challenge for global equine pharmaceuticals and supplements market during the forecast period.
The report segments the global equine pharmaceuticals and supplements market by product type, distribution channels and region. On the basis of product, the market is segmented as pharmaceuticals and supplements. Based on distribution channel, the market is segmented as veterinary hospitals, drugstores, and some others.
The companies covered in the report include Affymetrix, Bayer Animal Health, Boehringer Ingelheim, Celltrion Inc, Elanco Animal Health, Merck Animal Health, Merial, Novartis Animal Health, Vetoquinol and Zoetis.
Key Topics Covered:
2. Executive Summary
3. Global Insulation Materials Market Overview
4. Global Equine Pharmaceuticals and Supplements Market Analysis, by Product 2017-2023
5. Global Equine Pharmaceuticals and Supplements Market Analysis, by Distribution Channel 2017-2023
6. Global Equine Pharmaceuticals and Supplements Market Analysis, by Region 2017-2023
7. Company Profiles
- Bayer Animal Health
- Boehringer Ingelheim
- Celltrion Inc
- Elanco Animal Health
- Merck Animal Health
- Novartis Animal Health
For more information about this report visit http://www.researchandmarkets.com/research/mwdks7/equine